Krankenhaus Salem

Infigratinib (BGJ398) in previously treated patients with advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements: mature results from a multicentre, open-label, single-arm, phase 2 study

Milind Javle, Sameek Roychowdhury, Robin Kate Kelley et al. · ˜The œLancet. Gastroenterology & hepatology · 2021 · 398 citations

Surgical Oncology, Gastrointestinal Oncology, Medicine +11

HUMAN PAPILLOMAVIRUS INFECTIONS IN WOMEN WITH AND WITHOUT ABNORMAL CERVICAL CYTOLOGY

E M de Villiers, Achim Schneider, H Miklaw et al. · The Lancet · 1987 · 370 citations

Cervical Cancer Screening, Vulvar Diseases, Cervical Cancer +8

Acetaldehyde as an underestimated risk factor for cancer development: role of genetics in ethanol metabolism

Helmut K. Seitz, Felix Stickel · Genes & Nutrition · 2009 · 303 citations · Full text

Cancer Risk, Aldehyde Dehydrogenase, Biochemistry +12

Alcohol metabolism and cancer risk.

Helmut K. Seitz, Peter B. Becker · PubMed · 2007 · 287 citations · Full text

Pathology, Cancer Risk Factors, Chronic Alcohol Consumption +19

Genetic polymorphism of alcohol dehydrogenase in europeans: The ADH2*2 allele decreases the risk for alcoholism and is associated with ADH3*1

Emma Borràs, C. Coutelle, Albert Rosell et al. · Hepatology · 2000 · 262 citations · Full text